Cargando…

Oxaliplatin-Related Hypersensitivity Reactions: A Single Institution Series and Literature Review

Oxaliplatin-based chemotherapy is extensively used for the treatment of gastrointestinal tumors and other malignancies. Oxaliplatin-related hypersensitivity reactions (HSRs) are common during antitumor treatment. Several studies have been conducted to identify predictive risk factors for oxaliplatin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Barbin, Francesca, Ghidini, Michele, Panichi, Alessandra, Tomasello, Gianluca, Bareggi, Claudia, Galassi, Barbara, Denaro, Nerina, Ruatta, Fiorella, Cauchi, Carolina, Rossino, Maria Grazia, Garrone, Ornella
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9775529/ https://www.ncbi.nlm.nih.gov/pubmed/36552030 http://dx.doi.org/10.3390/biomedicines10123275

Ejemplares similares

Baseline Cytokine Profile Identifies a Favorable Outcome in a Subgroup of Colorectal Cancer Patients Treated with Regorafenib
por: Abbona, Andrea, et al.
Publicado: (2023)

Thrombotic Events during Lenvatinib Treatment: A Single Institution Experience
por: Denaro, Nerina, et al.
Publicado: (2022)

The Role of Cytokinome in the HNSCC Tumor Microenvironment: A Narrative Review and Our Experience
por: Denaro, Nerina, et al.
Publicado: (2022)

How Chemotherapy Affects the Tumor Immune Microenvironment: A Narrative Review
por: Merlano, Marco Carlo, et al.
Publicado: (2022)

The Tumor Microenvironment and the Estrogen Loop in Thyroid Cancer
por: Denaro, Nerina, et al.
Publicado: (2023)

Impact of BMI on Survival Outcomes of Immunotherapy in Solid Tumors: A Systematic Review
por: Indini, Alice, et al.
Publicado: (2021)

Circulating Cytokines in Metastatic Breast Cancer Patients Select Different Prognostic Groups and Patients Who Might Benefit from Treatment beyond Progression
por: Paccagnella, Matteo, et al.
Publicado: (2022)

How I treat squamous ENT cancer
por: Merlano, Marco Carlo, et al.
Publicado: (2019)

Cemiplimab in Ultra-Octogenarian Patients with Cutaneous Squamous Cell Carcinoma: The Real-Life Experience of a Tertiary Referral Center
por: Denaro, Nerina, et al.
Publicado: (2023)

The Appropriateness of Invasive Ventilation in COVID-19 Positive Cancer Patients: Proposal of a New Prognostic Score
por: Ghidini, Michele, et al.
Publicado: (2021)

Immune checkpoint inhibitor therapy for hepatocellular carcinoma
por: Ramai, Daryl, et al.
Publicado: (2022)

Characterization of the HER2 status in BRCA-mutated breast cancer: a single institutional series and systematic review with pooled analysis
por: Tomasello, G., et al.
Publicado: (2022)

Cytokine Profiling of End Stage Cancer Patients Treated with Immunotherapy
por: Merlano, Marco Carlo, et al.
Publicado: (2021)

Basal Cell Carcinoma and Hedgehog Pathway Inhibitors: Focus on Immune Response
por: Gambini, Donatella, et al.
Publicado: (2022)

Unusual Fatal Outcome Following Administration of a Combination of anti-PD1 and anti-CTLA4 in Metastatic Renal Cell Carcinoma: Liver Toxicity Case Report and a Literature Review
por: Denaro, Nerina, et al.
Publicado: (2021)

Hypersensitivity reactions related to oxaliplatin (OHP)
por: Brandi, G, et al.
Publicado: (2003)

Anti-Claudin Treatments in Gastroesophageal Adenocarcinoma: Mainstream and Upcoming Strategies
por: Grizzi, Giulia, et al.
Publicado: (2023)

Comparison of different second line treatments for metastatic pancreatic cancer: a systematic review and network meta-analysis
por: Petrelli, Fausto, et al.
Publicado: (2023)

Hypersensitivity to oxaliplatin: clinical features and risk factors
por: Parel, Marie, et al.
Publicado: (2014)

Survival benefit with adjuvant chemotherapy in stage III microsatellite-high/deficient mismatch repair colon cancer: a systematic review and meta-analysis
por: Tomasello, Gianluca, et al.
Publicado: (2022)

1765P Developing a risk assessment score for cancer patients during the COVID-19 pandemic
por: Indini, A., et al.
Publicado: (2020)

1689P The appropriateness of invasive ventilation in COVID-19 positive cancer patients: The hardest decision for oncologists
por: Ghidini, M., et al.
Publicado: (2020)

Coronavirus infection and immune system: An insight of COVID-19 in cancer patients
por: Indini, Alice, et al.
Publicado: (2020)

High-Salt Diet Exacerbates H. pylori Infection and Increases Gastric Cancer Risks
por: Balendra, Vyshnavy, et al.
Publicado: (2023)

Baseline Values of Circulating IL-6 and TGF-β Might Identify Patients with HNSCC Who Do Not Benefit from Nivolumab Treatment
por: Merlano, Marco Carlo, et al.
Publicado: (2023)

Clinical Analysis of Hypersensitivity Reactions to Oxaliplatin Among Colorectal Cancer Patients
por: Shen, Yuping, et al.
Publicado: (2018)

Clinical Significance of Molecular Subtypes in Western Advanced Gastric Cancer: A Real-World Multicenter Experience
por: Salati, Massimiliano, et al.
Publicado: (2023)

1696P Incidence of influenza-like illness (ILI) in cancer patients during COVID-19: The ONCOVID prospective observational study
por: Grossi, F., et al.
Publicado: (2020)

Renal Cell Carcinoma with bone metastases isn’t always bad
por: Ruatta, Fiorella, et al.
Publicado: (2019)

Oxaliplatin-induced cold hypersensitivity is due to remodelling of ion channel expression in nociceptors
por: Descoeur, Juliette, et al.
Publicado: (2011)

Meta-analysis of risk factors associated with oxaliplatin hypersensitivity reactions in cancer patients
por: Zhu, Linhui, et al.
Publicado: (2021)

Predictors of Lymph Node Metastasis in T1 Colorectal Cancer in Young Patients: Results from a National Cancer Registry
por: Ramai, Daryl, et al.
Publicado: (2021)

Oxaliplatin-induced neurotoxicity involves TRPM8 in the mechanism of acute hypersensitivity to cold sensation
por: Kono, Toru, et al.
Publicado: (2012)

Risk Factors for Oxaliplatin-Induced Hypersensitivity Reactions in Japanese Patients with Advanced Colorectal Cancer
por: Seki, Kyoko, et al.
Publicado: (2011)

Brain activity changes in a macaque model of oxaliplatin-induced neuropathic cold hypersensitivity
por: Nagasaka, Kazuaki, et al.
Publicado: (2017)

Immunotherapy in Head and Neck Squamous Cell Cancer
por: Denaro, Nerina, et al.
Publicado: (2018)

A Polyamine-Deficient Diet Prevents Oxaliplatin-Induced Acute Cold and Mechanical Hypersensitivity in Rats
por: Ferrier, Jérémy, et al.
Publicado: (2013)

Acute cold hypersensitivity characteristically induced by oxaliplatin is caused by the enhanced responsiveness of TRPA1 in mice
por: Zhao, Meng, et al.
Publicado: (2012)

The G2A receptor (GPR132) contributes to oxaliplatin-induced mechanical pain hypersensitivity
por: Hohmann, Stephan W., et al.
Publicado: (2017)

Differentiating between Laryngopharyngeal Dysesthesia and Hypersensitivity Reactions to Oxaliplatin and Addressing Dyspnea: 2 Case Reports
por: Kawaguchi, Fumitaka, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_a0f9o1ansktfphlhkung848nui